ATS 2024 Final Program

Click on the session title to view the speakers

211

MONDAY • MAY 20

811 CANCOV-Canadian Prospective Cohort of One-year Outcomes in Critically Ill Patients With COVID-19 and Their Family Caregivers - Impact of Protective Mechanical Ventilation on Lung Injury Recovery 812 The Association Between Dead Space and Oxygenation Index With Non-pulmonary Organ Dysfunction in Pediatric Acute Respiratory Distress Syndrome 813 Optimal Mode of Mechanical Ventilation for Adults in Shock: A Secondary Analysis of the Mode of Ventilation During Critical Illness Trial 814 Effect of Mechanical Ventilation Mode on Outcomes by Severity of Hypoxemia: A Secondary Analysis of the Mode of Ventilation During Critical Illness Trial 815 Stress Index During Mechanical Ventilation Post-lung Transplantation 816 Comparison of Non-invasive Techniques to Monitor the Response of Respiratory Effort to Changes in Ventilation and Sedation in Patients With Acute Hypoxemic Respiratory Failure 817 Prevalence and Characteristics of Pendelluft During Spontaneous Breathing in Patients With Moderate or Severe Acute Hypoxemic Respiratory Failure Manometry: The Lack of Correlation Between Diaphragm Thickening Fractions and D Pes in Pediatric Acute Respiratory Distress Syndrome Patients 819 Ventilation Distribution During Spontaneous Breathing Trial to Predict Liberation From Mechanical Ventilation: Preliminary Result of the VISION Study 820 Continuous Diaphragm Monitoring During the Spontaneous Breathing Trial Identifies Patients at Increased Risk of Extubation Failure 821 Measuring Diaphragm Displacement and Oxygen Consumption to Predict Weaning Success in Patients Requiring Prolonged Mechanical Ventilation 822 Physiological Evaluation of Accessory Muscle Activity and Function After Traumatic Spine Injury: The ACCESSIT Study 818 Diaphragm Ultrasounds Vs. Esophageal

BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

B103 PERSONALIZING CARE FOR PATIENTS WITH ACUTE RESPIRATORY FAILURE 2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 31A-C (Upper Level)

Poster Viewing

2:15-3:00

Discussion 3:00-4:15 801 Clinical Characteristics Associated With HFNC/NIV Treatment Failure in Non-intubated ARDS Patients Defined by 2023 New Global Definition of ARDS: A Retrospective Cohort Study of MIMIC-IV Database Retrospective Cohort Analysis of Hospitalized COVID-19 Patients 803 Characterizing NIV Mask Performance: A Trade-off Between Patient Effort and Applied Facial Pressure 804 The Use of the Rox Index to Guide High Flow Nasal Cannula Therapy and Need for Intubation Is Associated With Meaningful Patient Outcomes 805 Rapidly Improving Acute Respiratory Distress Syndrome: Clinical and Biologic Features 806 Heterogeneity in Association of Myocardial Injury and Mortality in Sepsis or ARDS by Inflammatory Phenotype 807 Latent Class Analysis Identifies Two Classes of Acute Hypoxic Respiratory Failure in Sepsis Distinguished by Lung Mechanics and Oxygenation 808 Mechanical Power-guided Lung Protective Ventilation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure (VentCoach) 809 Ventilator Mode and Risk Factors for High Tidal Volume in Mechanically Ventilated ICU Patients 810 Influence of the Magnitude and Synchrony of Breathing Efforts on the Mechanisms of P-sili in Early Acute Hypoxemic Respiratory Failure Is Modified by the Mode of Ventilation 802 Evaluating the New ARDS Definition in a

ATS 2024 Conference Program • San Diego, CA